A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of ALKS 7119 in Healthy Adults

Trial Profile

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of ALKS 7119 in Healthy Adults

Planning
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs ALKS 7119 (Primary)
  • Indications Agitation
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 Sep 2016 Planned initiation date changed from 1 Oct 2016 to 11 Jul 2016.
    • 02 Sep 2016 Planned number of patients changed to 40.
    • 29 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top